Glioma-associated stem cells: A novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas

Stem Cells

Volumn 32, Issue 5, 2014, Pages 1239-1253

  Bourkoula, Evgenia ^a   Mangoni, Damiano ^a   Ius, Tamara ^b   Pucer, Anja ^a   Isola, Miriam ^a   Musiello, Daniela ^a   Marzinotto, Stefania ^a   Toffoletto, Barbara ^a   Sorrentino, Marisa ^a   Palma, Anita ^a   Caponnetto, Federica ^a   Gregoraci, Giorgia ^a   Vindigni, Marco ^b   Pizzolitto, Stefano ^b   Falconieri, Giovanni ^b   De Maglio, Giovanna ^b,c   Pecile, Vanna ^d   Ruaro, Maria Elisabetta ^a   Gri, Giorgia ^a   Parisse, Pietro ^e   Casalis, Loredana ^e   Scoles, Giacinto ^a   Skrap, Miran ^b   Beltrami, Carlo Alberto ^a   Beltrami, Antonio Paolo ^a   Cesselli, Daniela ^a   more..

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^e SINCROTRONE TRIESTE   (Italy)

Author keywords

Exosomes; Glioma associated stem cells; Human glioma; Low grade glioma; Personalized medicine; Prognostic score

Indexed keywords

ADULT; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER PROGNOSIS; CANCER STEM CELL; CANCER SURVIVAL; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; EXOSOME; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GLIOMA; GLIOMA ASSOCIATED STEM CELL; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PHENOTYPE; PROGRESSION FREE SURVIVAL; STROMA; TUMOR GROWTH; UNIVARIATE ANALYSIS; AGED; ATOMIC FORCE MICROSCOPY; BRAIN TUMOR; CELL LINE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR MICROENVIRONMENT;

HOMEODOMAIN PROTEIN; NANOG PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; PHOTOPROTEIN; POU5F1 PROTEIN, HUMAN;

ADULT; AGED; BRAIN NEOPLASMS; CELL LINE; CELL PROLIFERATION; EXOSOMES; FEMALE; GENE EXPRESSION; GLIOMA; HOMEODOMAIN PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; LUMINESCENT PROTEINS; MALE; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84899031073     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1605     Document Type: Article

References (60)

1. Wen PY, Kesari S,. Malignant gliomas in adults. N Engl J Med 2008; 359: 492-507.
2. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
3. Ohgaki H,. Epidemiology of brain tumors. Methods Mol Biol 2009; 472: 323-342.
4. Soffietti R, Baumert BG, Bello L, et al. Guidelines on management of low-grade gliomas: Report of an EFNS-EANO task force. Eur J Neurol 2010; 17: 1124-1133.
5. Duffau H,. Surgery of low-grade gliomas: Towards a 'functional neurooncology'. Curr Opin Oncol 2009; 21: 543-549.
6. Sanai N, Chang S, Berger MS,. Low-grade gliomas in adults. J Neurosurg 2011; 115: 948-965.
7. Bourne TD, Schiff D,. Update on molecular findings, management and outcome in low-grade gliomas. Nat Rev Neurol 2010; 6: 695-701.
8. Stupp R, Tonn JC, Brada M, et al. High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (suppl 5): v190-193.
9. Vitucci M, Hayes DN, Miller CR,. Gene expression profiling of gliomas: Merging genomic and histopathological classification for personalised therapy. Br J Cancer 2011; 104: 545-553.
10. Salvati M, Pichierri A, Piccirilli M, et al. Extent of tumor removal and molecular markers in cerebral glioblastoma: A combined prognostic factors study in a surgical series of 105 patients. J Neurosurg 2012; 117: 204-211.
11. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
12. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-7021.
13. Pollard SM, Yoshikawa K, Clarke ID, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009; 4: 568-580.
14. Cesselli D, Beltrami AP, Pucer A, et al. Human low grade glioma cultures. In:, Duffau H, ed. Diffuse Low-Grade Gliomas in Adults. Springer, London, UK, 2013: 137-163.
15. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100: 57-70.
16. Hanahan D, Weinberg RA,. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674.
17. Place AE, Jin Huh S, Polyak K,. The microenvironment in breast cancer progression: Biology and implications for treatment. Breast Cancer Res 2011; 13: 227.
18. Cirri P, Chiarugi P,. Cancer-associated-fibroblasts and tumour cells: A diabolic liaison driving cancer progression. Cancer Metastasis Rev 2012; 31: 195-208.
19. Gonda TA, Varro A, Wang TC, et al. Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy? Semin Cell Dev Biol 2010; 21: 2-10.
20. Zhang J, Liu J,. Tumor stroma as targets for cancer therapy. Pharmacol Ther 2013; 137: 200-215.
21. Luga V, Zhang L, Viloria-Petit AM, et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2013; 151: 1542-1556.
22. Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18: 883-891.
23. Taylor DD, Gercel-Taylor C,. Exosomes/microvesicles: Mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol 2011; 33: 441-454.
24. Azmi AS, Bao B, Sarkar FH,. Exosomes in cancer development, metastasis, and drug resistance: A comprehensive review. Cancer Metastasis Rev 2013; 32: 623-642.
25. Thery C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006;Chapter 3:Unit 3 22.
26. Simons M, Raposo G,. Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 2009; 21: 575-581.
27. Charles NA, Holland EC, Gilbertson R, et al. The brain tumor microenvironment. Glia 2011; 59: 1169-1180.
28. Hoelzinger DB, Demuth T, Berens ME,. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 2007; 99: 1583-1593.
29. Felsberg J, Wolter M, Seul H, et al. Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing. Acta Neuropathol 2010; 119: 501-507.
30. Ius T, Isola M, Budai R, et al. Low-grade glioma surgery in eloquent areas: Volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: Clinical article. J Neurosurg 2012; 117: 1039-1052.
31. Skrap M, Mondani M, Tomasino B, et al. Surgery of insular nonenhancing gliomas: Volumetric analysis of tumoral resection, clinical outcome, and survival in a consecutive series of 66 cases. Neurosurgery 2012; 70: 1081-1093, discussion 1093-1084.
32. Beltrami AP, Cesselli D, Bergamin N, et al. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 2007; 110: 3438-3446.
33. Cesselli D, Beltrami AP, D'Aurizio F, et al. Effects of age and heart failure on human cardiac stem cell function. Am J Pathol 2011; 179: 349-366.
34. Cesselli D, Beltrami AP, Poz A, et al. Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. Int J Hepatol 2011; 2011: 120925.
35. Hinze A, Stolzing A,. Differentiation of mouse bone marrow derived stem cells toward microglia-like cells. BMC Cell Biol 2011; 12: 35.
36. Cesselli D, Beltrami AP, Rigo S, et al. Multipotent progenitor cells are present in human peripheral blood. Circ Res 2009; 104: 1225-1234.
37. Brescia P, Richichi C, Pelicci G,. Current strategies for identification of glioma stem cells: Adequate or unsatisfactory? J Oncol 2012; 2012:376894.
38. Velpula KK, Rehman AA, Chelluboina B, et al. Glioma stem cell invasion through regulation of the interconnected ERK, integrin alpha6 and N-cadherin signaling pathway. Cell Signal 2012; 24: 2076-2084.
39. Weiland A, Roswall P, Hatzihristidis TC, et al. Fibroblast-dependent regulation of the stem cell properties of cancer cells. Neoplasma 2012; 59: 719-727.
40. Kahlert C, Kalluri R,. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 2013; 91: 431-437.
41. Anido J, Saez-Borderias A, Gonzalez-Junca A, et al. TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell 2010; 18: 655-668.
42. Hamburg MA, Collins FS,. The path to personalized medicine. N Engl J Med 2010; 363: 301-304.
43. Johnson DR, Galanis E,. Incorporation of prognostic and predictive factors into glioma clinical trials. Curr Oncol Rep 2013; 15: 56-63.
44. Fomchenko EI, Dougherty JD, Helmy KY, et al. Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression. PLoS One 2011; 6: e20605.
45. Kim YG, Jeon S, Sin GY, et al. Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens. Childs Nerv Syst 2012; 29: 549-563.
46. Kong BH, Shin HD, Kim SH, et al. Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma. Int J Oncol 2013; 42: 1754-1762.
47. Estin C, Vernadakis A,. Primary glial cells and brain fibroblasts: Interactions in culture. Brain Res Bull 1986; 16: 723-731.
48. Reifenberger G, Szymas J, Wechsler W,. Differential expression of glial- and neuronal-associated antigens in human tumors of the central and peripheral nervous system. Acta Neuropathol 1987; 74: 105-123.
49. Tamagno I, Schiffer D,. Nestin expression in reactive astrocytes of human pathology. J Neurooncol 2006; 80: 227-233.
50. Couldwell WT, Yong VW, Dore-Duffy P, et al. Production of soluble autocrine inhibitory factors by human glioma cell lines. J Neurol Sci 1992; 110: 178-185.
51. Lal PG, Ghirnikar RS, Eng LF,. Astrocyte-astrocytoma cell line interactions in culture. J Neurosci Res 1996; 44: 216-222.
52. Buffo A, Rite I, Tripathi P, et al. Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain. Proc Natl Acad Sci USA 2008; 105: 3581-3586.
53. Paul G, Ozen I, Christophersen NS, et al. The adult human brain harbors multipotent perivascular mesenchymal stem cells. PLoS One 2012; 7: e35577.
54. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470-1476.
55. Kucharzewska P, Christianson HC, Welch JE, et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci USA 2013; 110: 7312-7317.
56. Wan F, Zhang S, Xie R, et al. The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research. Brain Pathol 2010; 20: 877-889.
57. Nichols JE, Niles JA, Dewitt D, et al. Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: Development of autologous cell based therapeutics for traumatic brain injury. Stem Cell Res Ther 2013; 4: 3.
58. Riemenschneider MJ, Jeuken JW, Wesseling P, et al. Molecular diagnostics of gliomas: State of the art. Acta Neuropathol 2010; 120: 567-584.
59. Weiler M, Wick W,. Molecular predictors of outcome in low-grade glioma. Curr Opin Neurol 2012; 25: 767-773.
60. Snuderl M, Batista A, Kirkpatrick ND, et al. Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell 2013; 152: 1065-1076.